ערך בספרים למניה: Athira Pharma, Inc. (ATHA)

Athira Pharma, Inc. (ATHA) is implementing AI robotics for the design of Alzheimer's compounds and reducing its carbon footprint through closed-loop water systems. The book value per common share on GURU.Markets reflects these processes, where 6.75 represents the latest metric reading. Management is currently revising its R&D strategy and seeking new neurological programs following unsuccessful tests of its lead drug candidate.

Investments in the robotic molecule screening of Athira Pharma, Inc. (ATHA) require an analysis of net assets, which determine the intrinsic value of the business minus liabilities. The current value of 6.75, reflected through the book value per share, demonstrates the actual size of the equity on paper, allowing the investor to assess the company's margin of safety relative to market volatility and development risks.